Phenotypic Shift of an Inflammatory Eosinophil Subset into a Steady-State Resident Phenotype after 2 Years of Vaccination against IL-5 in Equine Insect Bite Hypersensitivity
Open Access
- 5 October 2024
- journal article
- research article
- Published by MDPI AG in Veterinary Sciences
- Vol. 11 (10) , 476
Abstract
Eosinophils play a key role in allergic diseases such as insect bite hypersensitivity (IBH). Together with Th2 cells, they shape the course of inflammation in associated type I/IVb allergies. Therefore, a virus-like particle (VLP)-based vaccine targeting equine interleukin-5 (eIL-5), eIL-5-CuMV-TT, was developed to interfere with the IL-5 dependency of eosinophils by inducing the production of anti-self-IL-5 antibodies and alleviating clinical signs in IBH-affected horses. A previous study highlighted the presence of two eosinophil subsets, steady-state resident eosinophils (rEos) and inflammatory eosinophils (iEos), circulating in the blood of healthy and IBH-affected horses, distinguishable by the expression of integrin CD49f. Furthermore, eIL-5-CuMV-TT 1st year vaccination showed a significant decrease of total eosinophils and, in particular, iEos. Nevertheless, the very few remaining eosinophils still shared an iEos phenotype, reflected by bigger size and higher granularity. The aim of this study was to follow up on the phenotype of eosinophils in the 2nd year of vaccination of IBH-affected horses with eIL-5-CuMV-TT. Using flow cytometry analysis of the blood of healthy, IBH, IBH-placebo, and IBH-vaccinated horses, the percentage and count of cells were compared between groups with a focus on pair analysis of eosinophils in 1st and 2nd year vaccinated horses. Our data showed comparably low levels of iEos and a significant increase of rEos in 2nd year compared to 1st year vaccinated horses, suggesting a phenotypic shift toward a resident-like eosinophil population, primarily associated with the phenotype of healthy horses. The reduction of size, granularity, and expression of integrin CD49f in the 2nd year suggests a benefit of long-term treatment with the eIL-5-CuMV-TT vaccine.Keywords
Funding Information
- Swiss National Foundation (SNF) Bridge (40B2-0_194689)
This publication has 47 references indexed in Scilit:
- Differential effects of short- and long-term treatment with mepolizumab on eosinophil kinetics in blood and sputum in eosinophilic asthmaiScience, 2021
- Eosinophil diversity in asthmaBiochemical Pharmacology, 2020
- Eosinophils Mediate Basophil-Dependent Allergic Skin Inflammation in MiceJournal of Investigative Dermatology, 2019
- Treating insect-bite hypersensitivity in horses with active vaccination against IL-5Journal of Allergy and Clinical Immunology, 2018
- Shaping eosinophil identity in the tissue contexts of development, homeostasis, and diseaseJournal of Leukocyte Biology, 2018
- Basophils regulate the recruitment of eosinophils in a murine model of irritant contact dermatitisJournal of Allergy and Clinical Immunology, 2014
- MEDI-563, a humanized anti–IL-5 receptor α mAb with enhanced antibody-dependent cell-mediated cytotoxicity functionJournal of Allergy and Clinical Immunology, 2010
- IgE, mast cells, basophils, and eosinophilsJournal of Allergy and Clinical Immunology, 2010
- Eosinophil trafficking in allergy and asthmaJournal of Allergy and Clinical Immunology, 2007
- Eosinophils: A reviewVeterinary Research Communications, 1992